Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
151-165 of 350
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Project Oncology®Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
John Cho, MD, PhD, FRCPC
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Ryan Quigley
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
Project Oncology®The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
John Cho, MD, PhD, FRCPC
CAR T in Marginal Zone Lymphoma: Insights from the TRANSCEND FL Study
Project Oncology®CAR T in Marginal Zone Lymphoma: Insights from the TRANSCEND FL Study
Charles Turck, PharmD, BCPS, BCCCP
Sairah Ahmed, MD
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Project Oncology®Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Paola Marignani, PhD, EMBA
CAR T and Bispecifics in LBCL: Redefining Second-Line Therapy Choices
Project Oncology®CAR T and Bispecifics in LBCL: Redefining Second-Line Therapy Choices
Charles Turck, PharmD, BCPS, BCCCP
Samuel Yamshon, MD
- advertisement
Clinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Advances in Women's HealthClinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Ann Klopp, M.D., Ph.D.
Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
Advances in Women's HealthOptimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
Ann Klopp, M.D., Ph.D.
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Project Oncology®Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Project Oncology®Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
- advertisement
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Charles Turck, PharmD, BCPS, BCCCP
Evandro Bezerra, MD
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's RoundtableBlood-Based Screening for Colorectal Cancer: Benefits and Limitations
Aasma Shaukat, MD, MPH
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Clinician's RoundtablePostcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Aasma Shaukat, MD, MPH
